from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2977c/thiL

LFCtreatmentdescriptionclass of inhibitor

-0.298

Amikacinug/mL Amikacintranslation

-0.746

Cap5-10ug/mL Capreomycintranslation

-0.678

Rox10-50 ug/mL Roxithromycintranslation

-0.361

SM2-5 ug/mL Streptomycintranslation

-0.119

Tet5-10 ug/mL Tetracyclinetranslation

0.118

Rif0.2-5ug/mL Rifampicintranscription

0.053

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.239

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.674

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.226

CPZ10-50 ug/mL Chlorpromazinerespiration

1.667

Clofazimine10-13 ug/mL Clofaziminerespiration

0.735

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.713

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.181

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.508

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.944

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.331

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.057

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.366

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.453

KCN5-20 ug/mL Potassium cyaniderespiration

-0.426

NaN30.2-2 mM Sodium aziderespiration

-0.575

Nigericin50 uM Nigericinrespiration

0.050

TRC10-150 ug/mL Triclosanrespiration

0.257

TRZ10-25 ug/mL Thioridazinerespiration

0.839

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.170

menadione6-10 ug/mL Menadionerespiration

-0.513

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.514

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.271

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.442

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.243

NRP_1Non-replicating persistence stage 1dosRassociated

-0.685

Amp0.2mg/mL AmpicillincellWall

-0.013

Cephalexin20-100 ug/mL CephalexincellWall

0.003

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.509

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.657

EMB10-20 ug/mL EthambutolcellWall

-0.436

Eta12-40 ug/mL EthionamidecellWall

-0.373

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.210

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.829

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.779

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.126

BZA0.12 mg/mL BenzamidearomaticAmides

-0.164

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.457

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.406

H2O24 mM hydrogen peroxideDNAdamaging

0.768

Levo10 ug/mL LevofloxacinDNAdamaging

0.800

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.844

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.073

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.072

UVUV-irradiationDNAdamaging

-0.198

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.355

Antimycin12.5-50 ug/mL Antimycin A?

-1.004

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.152

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.156

PA8240.2-2 ug/mL PA-824?

0.137

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.612

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.768

Verapamil50 uM Verapamil?

-0.666

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.583

methoxatin10-20 ug/mL Methoxatin?